Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novanta | NOVT | Nov 21, 2024 | 164.72 | -0.13 |
Novartis ADR | NVS | Nov 21, 2024 | 103.85 | +0.74 |
Novavax | NVAX | Nov 21, 2024 | 8.04 | -0.25 |
Novo Integrated Sciences | NVOS | Nov 21, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 21, 2024 | 102.63 | -2.51 |
NovoCure | NVCR | Nov 21, 2024 | 17.09 | +1.36 |
Novonix ADR | NVX | Nov 21, 2024 | 1.92 | -2.54 |
NRG Energy | NRG | Nov 21, 2024 | 96.89 | +2.51 |
NRx Pharmaceuticals | NRXP | Nov 21, 2024 | 1.23 | +1.65 |
NSTS Bancorp | NSTS | Nov 21, 2024 | 11.19 | 0.00 |
Nu Holdings | NU | Nov 21, 2024 | 13.40 | +0.60 |
Nu Skin Enterprises | NUS | Nov 21, 2024 | 7.30 | -2.54 |
Nuburu | BURU | Nov 21, 2024 | 0.46 | -1.29 |
NuCana ADR | NCNA | Nov 21, 2024 | 1.27 | -0.78 |
Nucor | NUE | Nov 21, 2024 | 149.99 | +1.23 |
Nukkleus | NUKK | Nov 21, 2024 | 1.80 | +5.26 |
Nurix Therapeutics | NRIX | Nov 21, 2024 | 22.37 | -1.19 |
NuScale Power | SMR | Nov 21, 2024 | 27.67 | +7.50 |
Nustar Energy C Pref | NS-C | Nov 21, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 21, 2024 | 70.94 | +2.16 |
Nutex Health | NUTX | Nov 21, 2024 | 31.89 | +5.14 |
Nutriband | NTRB | Nov 21, 2024 | 4.94 | -0.80 |
Nutrien | NTR | Nov 21, 2024 | 46.87 | +2.14 |
Nuvalent A | NUVL | Nov 21, 2024 | 92.73 | +1.71 |
Nuvation Bio A | NUVB | Nov 21, 2024 | 2.70 | +4.65 |
Nuvectis Pharma | NVCT | Nov 21, 2024 | 4.90 | -3.35 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 21, 2024 | 12.74 | -0.39 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 21, 2024 | 13.86 | +0.43 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 21, 2024 | 11.60 | -0.17 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 21, 2024 | 12.10 | -0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.